duloxetine hydrochloride has been researched along with Chemical Dependence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Charnigo, RJ; Havens, JR; Lofwall, MR; Sun, J; Vickers-Smith, R; Walsh, SL | 1 |
| Bussone, G; Curone, M; D'Amico, D; Proietti-Cecchini, A; Savino, M; Tullo, V | 1 |
| Forde, G; Stanos, S | 1 |
1 review(s) available for duloxetine hydrochloride and Chemical Dependence
| Article | Year |
|---|---|
Practical management strategies for the chronic pain patient.
Topics: Administration, Cutaneous; Amines; Analgesics; Antidepressive Agents, Tricyclic; Carbamazepine; Chronic Disease; Clinical Protocols; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Monitoring; Drug Tolerance; Duloxetine Hydrochloride; Family Practice; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Lidocaine; Middle Aged; Pain; Practice Guidelines as Topic; Pregabalin; Randomized Controlled Trials as Topic; Substance-Related Disorders; Thiophenes; Treatment Outcome | 2007 |
1 trial(s) available for duloxetine hydrochloride and Chemical Dependence
| Article | Year |
|---|---|
Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder.
Topics: Adult; Aged; Analgesics; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Migraine Disorders; Obsessive-Compulsive Disorder; Substance-Related Disorders; Thiophenes; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for duloxetine hydrochloride and Chemical Dependence
| Article | Year |
|---|---|
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Databases, Factual; Duloxetine Hydrochloride; Gabapentin; Humans; Pharmacovigilance; Pregabalin; Risk Factors; Substance-Related Disorders; United States; United States Food and Drug Administration | 2020 |